Dr. Adnan Arif Shaukat
Consultant Clinical Oncologist at Aberdeen Royal Infirmary, Aberdeen, UK.
United Kingdom
Areas of expertise
- Radiotherapy including Stereotactic Radiotherapy
- Immunotherapy for Head and Neck Cancers and Melanoma
- General Oncology:
- CNS Cancer
- Head and Neck Cancer
- Gastrointestinal and Liver Cancer
- Neuroendocrine Cancer
About the expert
Dr. Adnan Arif Shaukat is a Consultant Clinical Oncologist at Aberdeen Royal Infirmary, Aberdeen, UK, with over 28 years of expertise in clinical oncology. He leads the Stereotactic Ablative Body Radiotherapy (SABR) service, serving as Principal or Co-Investigator across multiple national and international SABR and GI oncology trials. His clinical focus spans gastrointestinal, hepatobiliary, pancreatic, neuroendocrine, thyroid, and central nervous system cancers. He previously directed both the Radiation Division and Research Unit at Prince Sultan Military Medical City, Saudi Arabia, and authored the Malignant Spinal Cord Compression Guidelines at King Faisal Specialist Hospital.
Dr. Adnan Arif Shaukat is a Consultant Clinical Oncologist at Aberdeen Royal Infirmary, Aberdeen, UK, specialising in gastrointestinal, hepato-pancreato-biliary (HPB), neuroendocrine, thyroid, and central nervous system cancers. He leads the Stereotactic Ablative Body Radiotherapy (SABR) service at Aberdeen Royal Infirmary and brings extensive experience in linac-based stereotactic body radiotherapy, Gamma Knife radiosurgery, and immunotherapy with checkpoint inhibitors in head and neck and melanoma patients.
Dr. Shaukat is a Member of the Royal College of Physicians of London (MRCP, 1998) and a Fellow of the Royal College of Radiologists (FRCR, 2004), completing his Certificate of Completion of Specialist Training in 2005. He is a current member of the Editorial Board of the Saudi Medical Journal and serves on the Medical Advisory Group of the Upper GI Managed Clinical Network and the West of Scotland Ethics Committee.
He has made significant contributions to clinical research, serving as Principal or Co-Investigator in multiple national and international SABR and HPB oncology trials. His published work includes studies on concurrent nivolumab and radiotherapy for metastatic lung and renal cancers, atypical pulmonary toxicity secondary to erlotinib, and nodular lymphocyte-predominant Hodgkin lymphoma in Saudi Arabia. He is the author of the Malignant Spinal Cord Compression Guidelines at King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Dr. Shaukat has held senior international leadership roles, including Head of the Radiation Division and Head of the Research Unit at Prince Sultan Military Medical City, Riyadh, Saudi Arabia. He has contributed to national radiotherapy quality assurance and institutional review boards across multiple centres in the United Kingdom and Saudi Arabia, reflecting a sustained commitment to advancing oncology standards internationally.
-
Consultant Clinical Oncologist
2018 - TodayAberdeen Royal Infirmary, UK.
-
Head of Radiation Division
2014 - 2018Prince Sultan Military Medical City, Saudi Arabia.
-
Consultant Clinical Oncologist
2014 - 2018Prince Sultan Military Medical City
-
Head of Research Unit
2015 - 2018Prince Sultan Military Medical City, Saudi Arabia.
-
Consultant Radiation Oncologist
2011 - 2013King Fahad Specialist Hospital, Dammam.
-
Member of the Royal College of Physicians
London, UK.
1998
-
Fellow of Royal College of Radiologists
2004
-
Certificate of Completion of Consultant Specialist Training
-
Member of the Editorial Board for Saudi Medical Journal (2017)
-
Member of Quality Aassurance Committee in radiotherapy in King Fahad Specialist Hospital and Prince Sultan Military Medical City
-
Member of the Institutional Review Board iKing Fahad Specialist Hospital and Prince Sultan Military Medical City and Prince Sultan Military Medical City
-
Member of the Academic Affairs Committee in King Fahad Specialist Hospital and Prince Sultan Military Medical City
-
Member of Palliative care Committee in King Fahad Specialist Hospital
-
Member of the Medical Advisory group of Upper GI Managed Clinical Network
-
Member of West of Scotland Ethics Committee
Other experts inthe same speciality
Dr. Premini Mahendra
Consultant Haemato-Oncologist, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
More about the expert
Prof. Jaak Janssens
Head of oncology department, Limburg Oncological Center, Salvatore Hospital, Hasselt, Belgium.
More about the expert
Prof. Elias Obeid
Medical Director at the Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, Hackensack Meridian John Theurer Cancer Center, New Jersey, and Associate Professor at Hackensack Meridian School of Medicine, USA.
More about the expert
Dr. Rafael Moleron
Consultant Clinical Oncologist & Service Clinical Director for Oncology at Aberdeen Royal Infirmary, NHS Grampian, UK
More about the expert
Prof. Ioanna Nixon
Professor at Strathclyde University, and Consultant Clinical Oncologist at the Beatson West of Scotland Cancer Center, Glasgow, UK
More about the expert
Prof. Thierry Le Chevalier
Head of the Institute of Thoracic Oncology at Gustave Roussy Hospital in Villejuif, France, and Marie Lannelongue Hospital in Le Plessis Robinson, France.
More about the expert
Dr. Claire Paterson
Consultant Clinical Oncologist, the Beatson West of Scotland Cancer Centre & Honorary Clinical Associate Professor, University of Glasgow, UK
More about the expert
Doctor Derek Grose
Consultant Clinical Oncologist & Honorary Senior Lecturer at the Beatson West of Scotland Cancer Center, UK.
More about the expert
Prof. Mehmet Sen
Clinical oncologist, St James`s Institute of Oncology, Leeds, UK.
More about the expert
Prof. Robin Jones
Professor and Consultant Medical Oncologist at The Royal Marsden and Team Leader in Sarcoma Clinical Trials at The Institute of Cancer Research, UK.
More about the expert
Prof. Miklós Garami
Chief, Unit of Pediatric Oncology at 2nd Department of Pediatrics, Semmelweis University, and Associate Professor of Pediatrics at Semmelweis University.
More about the expert
Prof. Jaroslav Sterba
Professor of Pediatric Oncology and Head of Pediatric Oncology Department at University Hospital Brno, Czech Republic
More about the expert
Dr. Shadi Latta
Senior Partner / Consultant of Hematology and Oncology at Affeliated Oncologists, Chicago Ridge, IL, USA
More about the expert
Dr. Mauro Javier Oruezábal Moreno
Consultant Physician in Medical Oncology at University Hospital of Toledo, Toledo, Spain
More about the expert
Dr. Dionysis Papadatos-Pastos
Consultant Medical Oncologist at University College London Hospitals, UK.
More about the expert
Dr. Penny Kechagioglou
Consultant Clinical Oncologist and deputy Chief Medical Officer at University Hospitals Coventry and Warwickshire
More about the expert
Dr James M. Wilson
Consultant Clinical Oncologist and Honorary Associate Professor at University College London Hospitals NHS Foundation Trust/University College London
More about the expert
Prof. Michael Birrer
Director of the Winthrop P. Rockefeller Cancer Institute and Professor of Internal Medicine at University of Arkansas for Medical Sciences.
More about the expert
Prof. Abdur Rahman Shakir
Consultant and Assistant Professor of Hematology and Medical Oncology at the University of Illinois, Chicago, and Director of Sarah Bush Lincoln Regional Cancer Center, Chicago, USA
More about the expert
Dr. Giuseppe Barone
Consultant Paediatric Oncologist abd Neuroblastoma Clinical Lead at Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
More about the expert
Our network includes more than 1000 international experts in more than 1200 specialities and sub-specialities
See experts in all specialities